AU4314196A - Solid composition with improved solubility and absorbability - Google Patents

Solid composition with improved solubility and absorbability

Info

Publication number
AU4314196A
AU4314196A AU43141/96A AU4314196A AU4314196A AU 4314196 A AU4314196 A AU 4314196A AU 43141/96 A AU43141/96 A AU 43141/96A AU 4314196 A AU4314196 A AU 4314196A AU 4314196 A AU4314196 A AU 4314196A
Authority
AU
Australia
Prior art keywords
absorbability
solid composition
improved solubility
solubility
improved
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43141/96A
Inventor
Naoki Itoh
Atsushi Kajiyama
Kazuhiro Sako
Shigeru Yamazaki
Katsuhiko Yano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Publication of AU4314196A publication Critical patent/AU4314196A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU43141/96A 1994-12-21 1995-12-20 Solid composition with improved solubility and absorbability Abandoned AU4314196A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP6-318580 1994-12-21
JP31858094 1994-12-21
PCT/JP1995/002611 WO1996019239A1 (en) 1994-12-21 1995-12-20 Solid composition with improved solubility and absorbability

Publications (1)

Publication Number Publication Date
AU4314196A true AU4314196A (en) 1996-07-10

Family

ID=18100727

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43141/96A Abandoned AU4314196A (en) 1994-12-21 1995-12-20 Solid composition with improved solubility and absorbability

Country Status (2)

Country Link
AU (1) AU4314196A (en)
WO (1) WO1996019239A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011105070A1 (en) 2010-02-25 2011-09-01 パナソニック株式会社 Demand and supply control apparatus, demand and supply control method, and program

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2287971T3 (en) 1997-08-11 2007-12-16 Pfizer Products Inc. SOLID PHARMACEUTICAL DISPERSIONS WITH INCREASED BIODISPONIBILITY.
US6706283B1 (en) 1999-02-10 2004-03-16 Pfizer Inc Controlled release by extrusion of solid amorphous dispersions of drugs
ATE433318T1 (en) * 1999-02-10 2009-06-15 Pfizer Prod Inc OSMOTIC SYSTEM FOR ADMINISTRATION OF ACTIVE INGREDIENTS CONTAINING SOLID AMORPHOUS DISPERSIONS
EP1027886B1 (en) 1999-02-10 2008-07-09 Pfizer Products Inc. Pharmaceutical solid dispersions
YU43702A (en) 1999-12-23 2004-11-25 Pfizer Products Inc. Pharmaceutical compositions providing enhanced drug concentrations
US7115279B2 (en) * 2000-08-03 2006-10-03 Curatolo William J Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
US20040058956A1 (en) * 2000-12-11 2004-03-25 Yohko Akiyama Pharmaceutical composition having an improved water solubility
KR20040025881A (en) * 2000-12-11 2004-03-26 다케다 야쿠힌 고교 가부시키가이샤 Medicinal compositions having improved absorbability
US20100074949A1 (en) 2008-08-13 2010-03-25 William Rowe Pharmaceutical composition and administration thereof
ATE395044T1 (en) 2002-02-01 2008-05-15 Pfizer Prod Inc PHARMACEUTICAL COMPOSITIONS OF AMORPHIC DISPERSIONS OF ACTIVE INGREDIENTS AND LIPOPHILIC MICROPHASE-FORMING MATERIALS
MY128945A (en) * 2002-04-16 2007-03-30 Kowa Co Solid dispersion composition
DE60334391D1 (en) 2002-10-02 2010-11-11 Meiji Seika Kaisha ANTIBACTERIAL MEDICAL COMPOSITION WITH INCREASED ORAL ABSORPTION
JP2007501218A (en) 2003-08-04 2007-01-25 ファイザー・プロダクツ・インク Pharmaceutical composition of adsorbate of amorphous drug and lipophilic microphase-forming substance
PT1671635E (en) * 2003-10-08 2012-01-17 Meiji Seika Pharma Co Ltd Noncrystalline antibacterial composition containing cefditoren pivoxil
CA2546115C (en) 2003-11-14 2013-01-08 Ajinomoto Co., Inc. Solid dispersions or solid dispersion pharmaceutical preparations of phenylalanine derivatives
JP2005162696A (en) * 2003-12-04 2005-06-23 Nichiko Pharmaceutical Co Ltd Cefditoren pivoxil pharmaceutical preparation excellent in dissolution property
NZ587551A (en) 2004-06-24 2012-01-12 Vertex Pharma 5-Amino-phenol derivatives such as 5-amino-2,4-di-tert-butyl-phenol
JP4572296B2 (en) * 2004-07-21 2010-11-04 トーアエイヨー株式会社 Pimobendan oral dosage formulation
JP4572293B2 (en) * 2004-07-21 2010-11-04 トーアエイヨー株式会社 Pimobendan oral dosage formulation
KR101233235B1 (en) * 2005-08-26 2013-02-15 에스케이케미칼주식회사 Pharmaceutical composition of pranlukast solid-dispersion with improved early dissolution rate and the method of preparing the composition
SI3219705T1 (en) * 2005-12-28 2020-08-31 Vertex Pharmaceuticals Incorporated Pharmaceutical compositions of the amorphous form of n-(2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl)-1,4-dihydro-4-oxoquinoline-3-carboxamide
JP4572300B2 (en) * 2006-01-19 2010-11-04 トーアエイヨー株式会社 Pimobendan oral dosage formulation
WO2008114859A1 (en) * 2007-03-22 2008-09-25 Astellas Pharma Inc. Pharmaceutical composition containing pyrazole derivative
KR20100016093A (en) * 2007-03-30 2010-02-12 아지노모토 가부시키가이샤 Medicinal solid-dispersion preparation
WO2009123169A1 (en) 2008-04-02 2009-10-08 アステラス製薬株式会社 Amide derivative-containing pharmaceutical composition
RU2543714C2 (en) 2009-03-20 2015-03-10 Вертекс Фармасьютикалз Инкорпорейтед Method of obtaining modulators of cystic fibrousis transmembrane conductance regulator
CN103052382B (en) 2010-07-14 2014-10-22 千寿制药株式会社 Solid dispersion of alfa-ketoamide derivatives
BR112014021090B1 (en) 2012-02-27 2023-01-24 Vertex Pharmaceuticals Incorporated PHARMACEUTICAL COMPOSITION AND USE OF N-[2,4-BIS(1,1-DIMETHYLethyl)-5-HYDROXYPHENYL]-1,4-DIHYDRO-4-OXOQUINOLINE3-CARBOXAMIDE IN THE PREPARATION OF THE SAME
JP6336246B2 (en) * 2013-03-13 2018-06-06 大同化成工業株式会社 Nanoparticulate preparation and production method thereof
RU2749213C2 (en) 2014-10-07 2021-06-07 Вертекс Фармасьютикалз Инкорпорейтед Co-crystals of transmembrane conduction regulator modulators in cystic fibrosis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2727009B2 (en) * 1989-03-10 1998-03-11 ダイト株式会社 Sustained preparation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011105070A1 (en) 2010-02-25 2011-09-01 パナソニック株式会社 Demand and supply control apparatus, demand and supply control method, and program

Also Published As

Publication number Publication date
WO1996019239A1 (en) 1996-06-27

Similar Documents

Publication Publication Date Title
AU4314196A (en) Solid composition with improved solubility and absorbability
AU4112497A (en) Glp-2 derivatives
IL122447A0 (en) Pharmaceutical composition with anaestheric effect
AU2070795A (en) 3-aryl-4-hydroxy-delta3-dihydrothiophenone derivatives
AU2952997A (en) Thiocyano-triazolyl derivatives and their use as microbicides
AU4261697A (en) Compounds and methods
AU2896597A (en) Sulphonyl-mercapto-triazolyl derivatives and their use as microbicides
AU3906295A (en) Pyrrole derivatives
AU3308195A (en) Antihypertriglyceridemic composition
AU2972597A (en) Compositions and uses thereof
AU4161797A (en) Benzoperimidine-carboxylic acids and derivatives thereof
AU3200197A (en) New composition and methods
AU2894997A (en) Mercapto-imidazolyl derivatives and their use as microbicides
AU2084895A (en) DC-89 derivatives
AU3533595A (en) Chlorobenzene derivative and liquid-crystal composition containing the same
AU1454895A (en) Diphenyloxazoline derivatives
AU2152497A (en) Heterocyclic compounds and their preparation and use
AU1724697A (en) Novel aminophenol derivatives and their use
AU691690B2 (en) Acrolein-releasing composition and use thereof
AU3868497A (en) Benzenesulfone compounds and salts thereof
AU2813195A (en) Composition
AU1385595A (en) Aryl-5-methylene-oxazole derivatives
AU1619797A (en) Vinylene compounds and liquid-crystal composition
AU3776495A (en) Aryloxycycloalkenyl and aryloxyiminocycloalkenylhydroxyureas
AU2153197A (en) Cripowellins and synthetic derivatives thereof